鼻整形文献评点 · Rhinoplasty Daily Commentary
鼻尖客观测量新器械
Aesthetic Plastic Surgery · PMID 42993309 ·
doi事实｜自制装置测50名女性鼻尖四点，1.5N下位移8.6–11.2mm。
点评｜把鼻尖软硬度变成数字，方向有价值；但只有50例正常人、无术前术后对比，先当基线工具。
A custom device measured four nasal-tip points in 50 young Chinese women under 1.5 N; mean displacement was 8.6–11.2 mm. Quantifying tip flexibility is useful, but 50 normal subjects without before-after surgery data make this a baseline tool, not evidence of clinical benefit.
鼻尖血管瘤儿科
Pediatric Dermatology · PMID 42978517 ·
doi事实｜58例鼻尖血管瘤：口服普萘洛尔者3岁时后遗症67.9%，未治者100%。
点评｜早用普萘洛尔，2mg/kg多半够；外用噻吗洛尔别拿来拖延口服治疗。
In 58 infants with nasal-tip infantile hemangioma, propranolol was associated with fewer sequelae at age 3 (67.9% vs 100% untreated); low and high doses performed similarly. Start oral propranolol early at about 2 mg/kg/day, and do not let topical timolol delay it.
鼻整形术后镇痛RCT
Aesthetic Plastic Surgery · PMID 42864553 ·
doi事实｜212例鼻整形：布比卡因表面+阻滞，镇痛药更少、恶心呕吐更低、满意度最高。
点评｜II级证据；组合组省镇痛药、少恶心、满意度最高，表面组疼痛评分最低，按需选。
In a triple-blind RCT of 212 patients, combined topical and nerve-block bupivacaine reduced analgesic use and postoperative nausea/vomiting and gave the highest satisfaction. Level II evidence supports combining topical and block bupivacaine; topical alone gave the lowest pain scores but did not reduce analgesic consumption.
拉皮内镜面神经
Aesthetic Surgery Journal · PMID 42872381 ·
doi事实｜300例内镜拉皮，全程游离额颞支：无永久面神经损伤，暂时性额肌无力100%。
点评｜解剖清楚、可复制，代价是人人都暂时抬眉无力；单臂研究证明不了这买卖划算。
In 300 consecutive endoscopic facelifts with circumferential isolation of the fronto-temporal branches, no permanent nerve injury occurred, but all patients had transient frontalis weakness; median recovery was 14 days. The technique is reproducible, but universal temporary brow weakness and the lack of a control group leave the risk-benefit trade-off unproven.
隆胸脐入路系统综述
Aesthetic Plastic Surgery · PMID 42993310 ·
doi事实｜17项研究、13,210侧乳房：脐入路血肿0.2%、包膜挛缩1.7%、再干预2.3%。
点评｜数字漂亮，但几乎全是单臂回顾、随访短；适合极怕疤的人，不该当默认术式。
A meta-analysis of 17 studies and 13,210 breasts found pooled TUBA rates of hematoma 0.2%, capsular contracture 1.7% and reintervention 2.3%, with high satisfaction but mostly retrospective single-arm data. The complication rates look excellent, but moderate bias and short follow-up make TUBA an option for scar avoidance, not a new default.
隆胸假体长期随访
Aesthetic Surgery Journal · PMID 42987925 ·
doi事实｜5年随访：初次隆胸包膜挛缩MemoryShape 0.31%、Xtra 1.42%、普通圆型5.16%。
点评｜五年数据都算低，但研究没设计头对头，别拿这三个数直接排优劣。
In the GLOW 5-year interim analysis, Baker III/IV capsular contracture rates in primary augmentation were 0.31% for MemoryShape, 1.42% for MemoryGel Xtra and 5.16% for MemoryGel non-Xtra; the study was not designed for direct comparison. All three rates are low, but without a head-to-head design the ranking is descriptive, not a reason to switch implants.
还没有批注